Skip to main content

Major Depressive Disorder Clinical Insights

Kristian Dambrino, DNP, PMHNP-BC
Clinical Pearls
10/13/2026
Kristian Dambrino, DNP, APRN, MSN
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
Kristian Dambrino, DNP, PMHNP-BC, explores the role that dual-mechanism and multimodal medications may play in individualized major depressive disorder (MDD) care.
Kristian Dambrino, DNP,...
10/13/2026
Psych Congress NP Institute
Hara Oyedeji, DNP, PMHNP-BC, MSEd
Clinical Pearls
09/29/2026
Hara Oyedeji, APRN, PHMNP-BC, MS Ed
Hara Oyedeji, DNP, PMHNP-BC, MSEd, provides an overview of the relationship between sleep-wake disruptions and major depressive disorder (MDD).
Hara Oyedeji, DNP, PMHNP-BC, MSEd, provides an overview of the relationship between sleep-wake disruptions and major depressive disorder (MDD).
Hara Oyedeji, DNP, PMHNP-BC,...
09/29/2026
Psych Congress NP Institute
Kevin Williams, MS, MPAS, PA-C
Clinical Pearls
09/08/2026
Kevin Williams, MS, MPAS, PA-C
Kevin Williams, MS, MPAS, PA-C, walks clinicians through his patient-centered approach to finding the most appropriate adjunctive treatment option for major depressive disorder.
Kevin Williams, MS, MPAS, PA-C, walks clinicians through his patient-centered approach to finding the most appropriate adjunctive treatment option for major depressive disorder.
Kevin Williams, MS, MPAS, PA-C,...
09/08/2026
Psych Congress NP Institute
Desiree Matthews, PMHNP-BC
Clinical Pearls
08/31/2026
Desiree Matthews, PHMNP-BC
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC, offers a framework for choosing an initial antidepressant agent for major depressive disorder.
Desiree Matthews, PMHNP-BC,...
08/31/2026
Psych Congress NP Institute
Saundra Jain, MA, PsyD, LPC
Clinical Pearls
08/31/2026
Saundra Jain, MA, PsyD, LPC
Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses how clinicians can support patients through the early stages of treatment for major depressive disorder.
Psych Congress Steering Committee member Saundra Jain, MA, PsyD, LPC, discusses how clinicians can support patients through the early stages of treatment for major depressive disorder.
Psych Congress Steering...
08/31/2026
Psych Congress NP Institute
Erin Crown, MHS, PA-C, CAQ-Psychiatry
Clinical Pearls
08/25/2026
Erin Crown, MHS, PA-C, CAQ
Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares several communication strategies to effectively address patient concerns when considering augmentation for major depressive disorder (MDD).
Erin Crown, MHS, PA-C, CAQ-Psychiatry, shares several communication strategies to effectively address patient concerns when considering augmentation for major depressive disorder (MDD).
Erin Crown, MHS, PA-C,...
08/25/2026
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Insights
09/30/2025
Kristian Dambrino, DNP, APRN, MSN; Brittany B. Albright, MD, MPH
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH, consultant, Psych Congress, and Kristian Dambrino, DNP, PMHNP-BC, consultant, Psych Congress, discuss common pitfalls when it comes to diagnosing MDD and TRD, as well as tools that clinicians have at their disposal...
Brittany Albright, MD, MPH,...
09/30/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Insights
09/16/2025
Brittany B. Albright, MD, MPH; Kristian Dambrino, DNP, APRN, MSN
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC,, discuss referral practices for esketamine and transcranial magnetic stimulation for patients with depression.
Brittany Albright, MD, MPH, and...
09/16/2025
Psych Congress NP Institute
Brittany Albright and Kristian Dambrino
Clinical Insights
09/08/2025
Brittany Albright, MD, MPH; Kristian Dambrino, DNP, APRN, MSN
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and Kristian Dambrino, DNP, PMHNP-BC, discuss the difference between major depressive disorder and treatment-resistant depression, plus monoaminergic versus glutamatergic treatments.
Brittany Albright, MD, MPH, and...
09/08/2025
Psych Congress NP Institute
Julie Carbray and Kristian Dambrino
Clinical Insights
05/07/2025
Julie A. Carbray, PhD, APRN; Kristian Dambrino, DNP, APRN, MSN
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie Carbray, PhD, PMHNP-BC, PMHCNS-BC, APRN, and Kristian Dambrino, DNP, PMHNP-BC, discuss the role NMDA and AMPA receptors play in rapid-acting depression treatment.
In part 1 of this series, Julie...
05/07/2025
Psych Congress NP Institute